Avenue Therapeutics Inc. (ATXI) Fundamentals

Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain.
SHARE INFORMATION
Market Cap$ 21,396,954
Shares Outstanding1,475,652
Float808,508
Percent Float54.79%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.30
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions75
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months21,858
Institutional Holdings Percent22.0%
Institutional Sold Previous 3 Months1,105,706
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent7.2
Insider Sold Previous 3 Months-
Insider Shares Owned1,595,805
TRADING INFO
52 Week High$ 27.75
52 Week Low$ 3.00
52 Week High Change$ -32.40
21 Day Moving Average$ 5.5004
21 Day Extended Moving Average$ 6.6946
50 Day Moving Average$ 4.6319
50 Day Extended Moving Average$ 5.3391
200 Day Moving Average$ 6.877
200 Day Extended Moving Average$ 10.6657
10 Day Average Volume13,548,401
20 Day Average Volume7,033,138
30 Day Average Volume4,693,240
50 Day Average Volume2,819,660
Alpha0.013391
Beta-0.2532
Standard Deviation0.337754
R20.001528
7 Day Price Change$ 7.24
7 Day Percent Change99.72%
21 Day Price Change$ 11.03
21 Day Percent Change317.57%
30 Day Price Change$ 11.08
30 Day Percent Change324.16%
Month to Date Price Change$ 4.42
Month to Date Percent Change43.85%
Quarter to Date Price Change$ 4.42
Quarter to Date Percent Change43.85%
180 Day Price Change$ 7.55
180 Day Percent Change108.65%
200 Day Price Change$ 4.29
200 Day Percent Change42.03%
Year to Date Price Change$ 0.88
Year to Date Percent Change6.46%

Avenue Therapeutics Inc. (ATXI) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book28.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio2.50
Leverage Ratio1.20
Quick Ratio2.20
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-2.80
Enterprise Value$ 16,094,754
Price to Sales0.00
Price to Free Cash-4.20
PE High Last 5 Years-3.30
Price To Book28.40
Price To Cash Flow0.00
PE Low Last 5 Years-9.50
Price to Tangible Book28.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-510.24
Return on Equity-900.87
Return on Capital-847.42

Avenue Therapeutics Inc. (ATXI) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOAlexandra MacLean
Emplyoees4
Last AuditUE
CIK0001644963
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1140 Avenue of the Americas
9th Floor
New York, NY 10036
Websitehttps://www.avenuetx.com
Facsimile-
Telephone+1 781 652-4500
Emailjeremy@lifesciadvisors.com
Your Recent History
NASDAQ
ATXI
Avenue The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221005 16:23:33